Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2006
04/20/2006US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
04/20/2006US20060084657 Piperazine derivative
04/20/2006US20060084616 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR)
04/20/2006DE19941915B4 Aroma von gebratenen Kartoffeln und entsprechend aromatisierte Nahrungsmittel Aroma of fried potatoes and according flavored foods
04/20/2006DE102005045849A1 Preparation of benzocondensed oxyheterocycle, useful in liquid crystalline mixtures, comprises regioselective opening of e.g. oxetane by metallized fluoroaromates and cyclizing the obtained propanol derivative by non-nucleophilic base
04/20/2006CA2583497A1 Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
04/19/2006EP1646616A2 Combretastatin derivatives with cytotoxic action
04/19/2006EP1646608A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
04/19/2006EP1478617A4 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof
04/19/2006EP1420784B1 Compounds effecting glucokinase
04/19/2006EP1347983B1 Process for the production of anhydrosugar alcohols
04/19/2006EP1120419B1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
04/19/2006EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments
04/19/2006EP1016408B1 Novel paharmaceutical use of c-c chemokine production inhibitors
04/19/2006CN1761659A Intermediates for the preparation of citalopram and escitalopram
04/19/2006CN1761658A Process for the preparation of a cyano-isobenzofuran
04/19/2006CN1761657A EP4 receptor antagonists
04/19/2006CN1761650A Compounds, a process for their preparation and their use as dyes and pigments
04/19/2006CN1761646A Cannabinoid receptor ligands
04/19/2006CN1760191A Method for batch extracting rectified purified tetrahydrofuran
04/19/2006CN1252130C Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same
04/19/2006CN1252073C Process for preparation of garcinia acid
04/19/2006CN1252060C Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method
04/19/2006CN1252055C Biphenyl carboxamides compounds
04/18/2006US7030262 3-Amino-2-hydroxyalkanoic acids and their prodrugs
04/18/2006US7030252 Cyanation by converting the 5-formyl compound with hydroxylamine, dehydration to form antidepressant agents; chemical synthesis, salt formation, forming enantiomers; serotonin reuptake inhibitors for treating dementia and cerebrovascular disorders
04/18/2006US7030239 Compounds to treat Alzheimer's disease
04/18/2006US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
04/18/2006US7030153 Including methylsulfonyl attachment, treating arthritis, with analgesic activity without erosion of the stomach, side effect reduction
04/18/2006US7030130 Benzofuran derivatives and their use as antibacterial agents
04/18/2006US7029606 Hyperpolarizable organic chromophores
04/18/2006CA2360943C N2-phenylamidine derivatives
04/18/2006CA2207443C Tricyclic compounds
04/13/2006WO2006038606A1 Biaryl derivative
04/13/2006WO2006037996A1 Novel cyclic and acyclic propenones for treating cns disorders
04/13/2006WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases
04/13/2006WO2006037957A1 Process for the purification of 1, 4-butanediol
04/13/2006WO2006037761A1 New histone deacetylases inhibitors
04/13/2006WO2006037714A2 Process for the preparation of citalopram and escitalopram
04/13/2006WO2006037449A2 Iron complex for use in the treatment and/or prevention of nutritional disorders
04/13/2006WO2005007621A3 Ubiquitin ligase inhibitors
04/13/2006US20060079700 Reacting compounds such as 5-substituted-3H-isobenzofuran-1-one with with a cyanide source optionally in the presence of a catalyst to produce 5-cyano-3H-isobenzofuran-1-one
04/13/2006DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives
04/13/2006CA2583310A1 Process for producing mycophenolic acid using penicillium arenicola bicc7673
04/13/2006CA2581539A1 Process for the purification of 1, 4-butanediol
04/13/2006CA2581195A1 Process for the preparation of citalopram and escitalopram
04/13/2006CA2580221A1 Novel cyclic and acyclic propenones for treating cns disorders
04/12/2006EP1644320A1 Indane derivates as muscarinic receptor agonists
04/12/2006EP1643984A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents
04/12/2006EP1643960A2 Arylsulfonamide derivatives
04/12/2006EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
04/12/2006EP1358183B1 Cysteine protease inhibitors
04/12/2006EP1311499B1 Bicyclic compounds as h3 receptor ligands
04/12/2006EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation
04/12/2006EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
04/12/2006EP1003736B1 Substituted 4-benzoyl-pyrazoles
04/12/2006CN1757636A Method for preparing prostaglandin F derivative, and novel intermediate thereof
04/12/2006CN1250516C Process for preparation of aniline compounds
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006US7026476 Intermediate arylamine compounds
04/11/2006US7026351 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
04/11/2006US7026346 Anticancer agents
04/11/2006US7026339 Inhibitors of HCV NS5B polymerase
04/11/2006US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents
04/11/2006US7026307 Decyclization of a 1-heterocyclylmethyl-2-nitroimino-1,3,5-hexahydrotriazine compound with hydrogen halide in presence of a nitrile to form a 1-heterocyclylmethyl-2-nitroguanidine compound
04/11/2006US7026021 Fluorinated heterocycles and their use in liquid-crystal mixtures
04/11/2006CA2181570C Metalloproteinase inhibitors
04/06/2006WO2006036031A1 Fused furan derivative and use thereof
04/06/2006WO2006034805A1 Method for the distillative processing of tetrahydrofuran
04/06/2006US20060074253 Process for the preparation of citalopram
04/06/2006US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors
04/06/2006US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
04/06/2006US20060074128 Substituted 2-phenyl benzofurans as estrogenic agents
04/05/2006EP1642895A2 Novel substituted naphthopyrans
04/05/2006EP1642888A1 compounds for modulating the rage receptor
04/05/2006EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof
04/05/2006EP1641740A1 Method for producing an optically active nitro compound
04/05/2006EP1140846B1 Aspartic protease inhibitors
04/05/2006CN1756758A Novel cantharidimide and norcantharidimide derivant and its application in medicine
04/05/2006CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
04/05/2006CN1754881A Chemical synthetic process of D-fluorescein and device therefor
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1754868A Method for converting sodium gulonate to gulonic acid in Vit C production
04/05/2006CN1249067C Extracting process for bilobalide A, B, C and its preparation
04/05/2006CN1249053C Nitrate salt of anti-ulcer medicine
04/05/2006CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
04/04/2006US7022857 Preparation of substituted aromatic compounds
04/04/2006US7022825 Polyketides and antibiotics
04/04/2006US7022736 Enzyme inhibitors
04/04/2006US7022733 Estrogen receptor modulators for treating or inhibiting endometriosis
04/04/2006US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
04/04/2006CA2166315C Process for the preparation of thalidomide
04/04/2006CA2132134C Benzofuran-2-ones as stabilisers
03/2006
03/31/2006WO2005027900A1 Benzofuran derivatives
03/31/2006CA2580563A1 Benzofuran derivatives
03/30/2006WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006WO2006034269A1 Expeditious synthesis of dpd
03/30/2006WO2006032994A2 Muscarinic receptor antagonists
03/30/2006WO2006016724A3 Liquid-crystalline compounds, compositions and thin films